|
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation(JOTROL TM) (via DSS) |
|
|
|
|
ROSMAP2 GWAS |
|
|
658816 |
|
ROSMAP GWAS |
|
|
750173 |
|
Results of gene-based weighted burden analyses using SCOREASSOC and GENEVARASSOC applied to the ADSP discovery sample |
|
|
|
|
Results of gene - based weighted burden analyses using SCOREASSOC and GENEVARASSOC and multivariate analyses of variants near APOE applied to the ADSP Discovery Case - Control Based Extension Study. |
|
|
|
|
Resolving mutations in challenging genomic regions to test association with disease phenotypes (via DSS) |
|
|
|
|
Proteomic profiling identified plasma biomarkers for SARS-CoV-2 infection and severity of COVID-19 patients (via DSS) |
|
|
|
|
Progressive Supranuclear Palsy (PSP) Summary Statistics- Hoglinger et al. (2011) |
|
|
|
|
Progressive Supranuclear Palsy (PSP) Summary Statistics – Farrell et al., 2024 (via DSS) |
|
|
|
|
Progressive Supranuclear Palsy (PSP) GWAS |
|
|
567165 |
|
Profiling microglia expression profiles in AD using single-nuclei RNA-seq (via DSS) |
|
|
|
|
Prediction of Psychosis in Alzheimer Disease Summary Statistics - DeMichele-Sweet, et. al. 2021 |
|
|
|
|
Prediction of Psychosis in Alzheimer Disease |
|
|
41601 |
|
Oligodendrocytes single-cell whole genome and RNA sequencing (via DSS) |
|
|
|
|
OHSU GWAS |
|
|
353202 |
|
Novel risk loci and pathways associated with Alzheimer disease in African Americans: A GWAS and meta-analysis summary statistics- Kunkle et al. (2020) |
|
|
|
|
Northshore Exome Chip |
|
|
243162 |
|
NLTCS (The National Long Term Care Survey) SNP DATA I |
|
|
2372784 |
|
NIA-LOAD GWAS |
|
|
620901 |
|
NIA-LOAD (ADGC subset) GWAS |
|
|
572587 |
